| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |